Tag Archives: Asia Pacific

Biotech companies in emerging markets

20 Sep

As biotech companies in emerging markets move from imitation to innovation, they will reach a decision point – focus on local health demands or develop medicines for industrialized countries with larger markets. The authors suggest that biotech companies can meet both demands through an entrepreneurial model. However. the logic of the entrepreneurial model is such […]

Lilly sees potential of Chinese market

06 Apr

Opportunities in emerging markets for pharmaceutical companies may off-set job losses in established markets. This report about Lilly’s plans for China provides some insight into their plans and their moves to meet the growing demand for health care products in China. Joao ***************** Eli Lilly and Co. looks at China and sees the world’s most […]

China drug list seen boosting Western firms’ sales

25 Mar

The National Reimbursement Drug List is being updated for the first time since 2004 with many Western drugs added to the category that entitles patients to a rebate of up to 50 percent. New entrants include Astra’s cholesterol fighter Crestor and its heartburn pill Nexium, along with Sanofi’s anti-clotting medicine Plavix. The fact that hospitals […]

S’pore’s biomedical output grew to $21b last year

18 Mar

SINGAPORE’S biomedical manufacturing output grew at a robust pace last year to reach $21 billion and employed 13,000 people, the Economic Development Board (EDB) said yesterday. According to Spring Singapore, last year’s production outpaced the previous year’s $19 billion and a value-add of $10.6 billion. Last year, the sector attracted cumulative capital of $1.2 billion […]

Drugmakers agree landmark vaccines deal for poor

18 Mar

Several drug firms have agreed a landmark deal to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations, according to the global immunisation alliance that is overseeing the deal. Leading manufacturers of such vaccines include GlaxoSmithKline and Pfizer. The agreement is the first under a new scheme called an […]

Drug sales in emerging mkts to soar: study

17 Mar

Gone are the days when developing countries contributed miniscule portions to total global revenue for pharmaceutical and biotech companies. This news and the report from IMS point to a new reality fast approaching in the horizon. The “G17” (in honor of the ever expanding G8 and now G20 group of nations) of pharmaceutical consumption will […]

The Next Big Opportunity for Big Pharma Is BRIC

14 Mar

The pharmaceutical landscape is rapidly changing on a global scale. Big Pharma no longer wants to dominate just in the US market — it’s increasingly chasing opportunities in new emerging markets like China, India, and Africa. The latest company to dip its toe in the emerging tide is AstraZeneca (AZN). The Anglo-Swedish pharmaceutical company announced […]

Bayer Schering bares $1.4-billion Asian expansion

14 Mar

SINGAPORE – Bayer Schering Pharma Asia Pacific is aiming to grow its business faster than the industry average this year after reporting a 13 percent improvement in sales last year to EUR 1.04 billion, ($1.41 billion) from EUR 910 million ($1.237.6 billion) in 2008, despite the global crisis. In a press briefing here on Friday, […]

Carapinha Logo